skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. AIDX: Hi there, your thoughts on AIDX and SPB Q1 results? [HealWELL AI Inc. Class A Subordinate Voting Shares]
You can view 2 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi there, your thoughts on AIDX and SPB Q1 results?

How do you view AIDX and SPB now going forward?

What is expected of WELL?

Thanks!
Asked by Hussein on May 14, 2025
5i Research Answer:

WELL expectations are EPS 3c, revenue $294.1M

SPB EPS of 66c beat estimates of 35c; revenue of $1.00B beat estimates of $686m. EBITDA of $260.5M beat estimates by 5%. It was a Q1 record for some metrics. EBITDA rose 11% (19% per share). Free cash flow rose 54%. 2.6% of the shares were bought and cancelled. Certainly this was a solid quarter overall.

AIDX EPS of -8c missed estimates of -5c; revenue of $14.1M beat estimates of $13.66M. EBITDA of - $3.3M beat estimates of -$6.0M. Revenue rose 204%, with acquisitions and solid growth in the AI and data business. Margins rose 2 points to 46%. The Orion Health acquisition has now closed and will show up in the next quarter. AIDX plans to reduce costs by $3M. The outlook calls for very strong revenue growth but more losses over the next two years. But we are comfortable with the numbers.